Cerapedics Inc. is a global orthopedics company known for its commitment to redefining the path to bone repair, as encapsulated in its slogan. Founded in 2001 and headquartered in Westminster, CO, this commercial-stage company operates within the Biotechnology, Health Care, and Medical Devices industries.
The company's innovation is evident in its FDA-approved products, namely the PearlMatrix™ Bone Graft and i-FACTOR® Bone Graft. These products play a crucial role in spine surgeries, including TLIF in the lumbar spine and ACDF in the cervical spine, and are part of over four million annual procedures worldwide in orthopedics and trauma interventions.
Cerapedics' ability to heal bones faster and more effectively positions it strategically in a growing market. While recent investment data for Cerapedics is unavailable, its established product line and global reach make it an attractive prospect for investors seeking to leverage innovations in medical technology. The company's trajectory indicates potential for significant impact in the orthopedics space, providing a compelling case for venture investment.